SSMXY (Sysmex) Debt-to-Asset : 0.09 (As of Sep. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Sysmex Debt-to-Asset?

Sysmex's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $58 Mil. Sysmex's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $331 Mil. Sysmex's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was $4,323 Mil. Sysmex's debt to asset for the quarter that ended in Sep. 2024 was 0.09.

Sysmex Debt-to-Asset Historical Data

The historical data trend for Sysmex's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sysmex Debt-to-Asset Chart

Sysmex Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Asset

Get a 7-Day Free Trial

0.06

0.05

0.04

0.09

Sysmex Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Asset	Get a 7-Day Free Trial															0.05	0.09	0.09	-	0.09

Competitive Comparison of Sysmex's Debt-to-Asset

For the Medical Instruments & Supplies subindustry, Sysmex's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sysmex's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sysmex's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Sysmex's Debt-to-Asset falls into.

Sysmex Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Sysmex's Debt-to-Asset for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(57.797	+	311.577)	/	4131.129
	=	0.09

Sysmex's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(58.494	+	330.974)	/	4323.496
	=	0.09

Sysmex (OTCPK:SSMXY) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Sysmex Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Sysmex's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Sysmex Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sysmex Corp (OTCPK:SSMXY) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

SSMXF:USA 6869:Japan 0YX:Germany 0YX:Germany

Address

1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, JPN, 6510073

Website

http://www.sysmex.co.jp

Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.

Sysmex Headlines

From GuruFocus

Q2 2020 Sysmex Corp Earnings Presentation Transcript

By GuruFocus Research • 02-15-2024

Vanguard Health Care Fund Gains 4 International Stocks in 2nd Quarter

By Sydnee Gatewood Sydnee Gatewood • 08-04-2017

Matthews Japan Fund Comments on Sysmex

By Vera Yuan Vera Yuan • 02-05-2015

Full Year 2019 Sysmex Corp Earnings Presentation Transcript

By GuruFocus Research • 02-15-2024

Q3 2020 Sysmex Corp Earnings Call Transcript

By GuruFocus Research • 02-15-2024

Matthews Japan Fund Comments on Sysmex

By Sydnee Gatewood Sydnee Gatewood • 10-21-2020

Q1 2020 Sysmex Corp Earnings Call Transcript

By GuruFocus Research • 02-15-2024

Matthews Japan Fund Q4 2014 Commentary

By Vera Yuan Vera Yuan • 02-05-2015